Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion
Accelrys (ACCL) SG Cowen Phil Nadeau Discontinued NA
Nadeau dropped coverage because the software provider falls outside SG Cowen's biotech coverage area. ACCL closed Friday at $6.26, up $0.16 on the week.
Alkermes (ALKS) Pacific Growth Patricia Bank New Overweight
Bank said ALKS should trade "around the $16 level" over the next year. ALKS closed Friday at $12.13, up

Read the full 688 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers